Neurology Central

Repurposing of malaria drug to halt ALS disease progression

Researchers from the Hospital for Special Surgery (NY, USA) and other centres have discovered that pyrimethamine, a drug orignally used to treat malaria, lowers the levels of a biomarker linked to the inherited form of amyotrophic lateral sclerosis (ALS). The results, recently published in Annals of Neurology, suggest pyrimethamine could be useful in treating ALS.
To view restricted content, please:



Leave A Comment